Form 4: Surgery Partners Executive Harrison R. Bane Acquires Restricted Stock Awards

Harrison R. Bane, American Group President at Surgery Partners, Inc., reports acquisition of restricted stock awards on February 28, 2024.

Summary

• On February 28, 2024, Harrison R. Bane, American Group President of Surgery Partners, Inc., acquired 10,262 restricted stock awards (RSAs) at a price of $31.18.
• These RSAs vest in three equal annual installments starting on the first anniversary of the grant date.
• Additionally, Bane acquired 1,443 RSAs at the same price, vesting in two equal annual installments beginning on the first anniversary of the grant date.
• Following these transactions, Bane directly owns 58,414 shares of Surgery Partners, Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock by an executive is generally viewed as a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of restricted stock awards by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The restricted stock awards vest over the next two to three years, incentivizing the executive to contribute to the company's long-term success.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and their confidence in the company's prospects.

Stakeholder Impact

• The acquisition of restricted stock awards by a company executive can positively influence shareholder confidence.

Key Dates